Efficacy and safety of personalized optimal PD-(L) 1 combinations in advanced NSCLC: a network meta-analysis

X Chu, W Tian, J Ning, R Zhou - JNCI: Journal of the National …, 2024 - academic.oup.com
Abstract Introduction Programmed death 1 (PD-1)/programmed death 1 ligand 1 (PD-L1)-
directed immunotherapy has revolutionized the treatments for advanced non-small cell lung …

Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases

S Amin, M Baine, C Lin - Immunotherapy, 2023 - Taylor & Francis
Aim: To investigate the association of stereotactic radiation therapy (SRT) or whole-brain
radiation therapy (WBRT) plus immunotherapy with the overall survival (OS) of cancer …

Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at …

GP Ostdiek-Wille, S Amin, S Wang, C Zhang, C Lin - PeerJ, 2023 - peerj.com
Background and purpose Stereotactic radiosurgery (SRS) and fractionated stereotactic
radiation therapy (SRT) are both treatments shown to be effective in treating brain …

Beyond Chemotherapy: The Promise of Immunotherapy in Cancer Care and Advancements in Cancer Therapy

K Zaid - Research & Reviews: A Journal of Immunology, 2023 - research-reels.com
Recent advances in cancer immunotherapy harness the immune system to precisely target
cancer. These include the use of immunosuppressive agents, NK cell recovery, changes in …

Effect of targeted tumor immunotherapy combined with psychological intervention on prolonging survival of malignant patients

ZH Wang, WZ Chen, ZM Yao - Archives of Clinical Psychiatry, 2022 - archivespsy.com
Objective: To explore the effect of targeted tumor immunotherapy combined with
psychological intervention on prolonging the survival of malignant patients. Methods 86 …